Quercetin-POM (pivaloxymethyl) conjugates: Modulatory activity for P-glycoprotein-based multidrug resistance

Phytomedicine

Volumn 22, Issue 7-8, 2015, Pages 778-785

  Kim, Mi Kyoung ^a   Park, Kwang Su ^a   Choo, Hyunah ^b   Chong, Youhoon ^a  

^a Konkuk University   (South Korea)

^b Korea Institute of Science and Technology   (South Korea)

Author keywords

Modulator; Multidrug resistance (MDR); P glycoprotein (Pgp); Pivaloxymethyl; Quercetin

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ANTINEOPLASTIC AGENT; DACTINOMYCIN; DOXORUBICIN; MULTIDRUG RESISTANCE PROTEIN; PACLITAXEL; QUERCETIN; QUERCETIN PIVALOXYMETHYL CONJUGATE; UNCLASSIFIED DRUG; VERAPAMIL; VINBLASTINE; 7-O-PIVALOXYMETHYLQUERCERTIN; ABCB1 PROTEIN, HUMAN;

ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOTOXICITY; DRUG BINDING SITE; DRUG UPTAKE; FIBROBLAST; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IN VITRO STUDY; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; WESTERN BLOTTING; ANALOGS AND DERIVATIVES; BINDING SITE; CHEMICAL STRUCTURE; DRUG EFFECTS; DRUG RESISTANCE; METABOLISM; MULTIDRUG RESISTANCE; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; BINDING SITES; CELL LINE, TUMOR; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; HUMANS; MOLECULAR STRUCTURE; P-GLYCOPROTEINS; QUERCETIN; VERAPAMIL;

EID: 84934899473     PISSN: 09447113     EISSN: 1618095X     Source Type: Journal    
DOI: 10.1016/j.phymed.2015.05.055     Document Type: Article

References (29)

1. Ambudkar S.V., Dey S., Hrycyna C.A., Ramachandra M., Pastan I., Gottesman M.M. Biochemical, cellular, and pharmacological aspects of the multidrug transporter Annu. Rev. Pharmacol. Toxicol. 39 1999 361 398
2. Aszalos A., Weaver J.L. Estimation of drug resistance by flow cytometry Meth. Mol. Biol. 91 1998 117 122
3. Bellamy W.T. P-glycoprotein and multidrug resistance Annu. Rev. Pharmacol. Toxicol. 36 1996 161 183
4. Biedler J.L., Riehm H. Cellular resistance to actinomycin D in Chinese hamster cells in vitro: cross-resistance, radioautographic, and cytogenetic studies Cancer Res. 30 1970 1174 1184
5. Boulton D.W., Walle U.K., Walle T. Fate of the flavonoids quercetin in human cell lines: chemical instability and metabolism J. Pharm. Pharmacol. 51 1999 353 359
6. Chan K-F., Zhao Y., Burkett B.A., Wong I.L.K., Chow L.M.C., Chan T.H. Flavonoid dimers as bivalent modulators for P-glycoprotein-based multidrug resistance, synthetic apigenin homodimers linked with defined-length poly(ethylene glycol) spacers increase drug retention and enhance chemosensitivity in resistant cancer cells J. Med. Chem. 49 2006 6742 6759
7. Chan K.-F., Wong I.L.K., Kan J.W.Y., Yan C.S.W., Chow L.M.C., Chan T.H. Amine linked flavonoid dimers as modulators for P-glycoprotein-based multidrug resistance: structure-activity relationship and mechanism of modulation J. Med. Chem. 55 2012 1999 2014
8. Conquer J.A., Maiani Q., Azzini E., Raguzzini A., Holub B.J. Supplementation with quercetin markedly increases plasma quercetin concentration without effect on selected risk factors for heart disease in healthy subjects J. Nutr. 128 1998 593 597
9. Critchfield J.W., Welsh C.J., Phang J.M., Yeh G.C. Modulation of adriamycin accumulation and efflux by flavonoids in HCT-15 colon cells. Activation of P-glycoprotein as a putative mechanism Biochem. Pharmacol. 48 1994 1437 1445
10. Davis J.M., Murphy E.A., McClellan J.L., Carmichael M.D., Gangemi J.D. Quercetin reduces susceptibility to influenza infection following stressful exercise Am. J. Physiol. Regul. Integr. Comp. Physiol. 295 2008 R505 R509
11. Ferry D.R., Smith A., Malkhandi J., Fyfe D.W., deTakats P.G., Anderson D., Baker J., Kerr D.J. Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition Clin. Cancer Res. 2 1996 659 668
12. Gottesman M.M., Pastan I., Ambudkar S.V. P-glycoprotein and multidrug resistance Curr. Opin. Gen. Dev. 6 1996 610 617
13. Kim M.K., Park K.-S, Lee C., Park H.R., Choo H., Chong Y. Enhanced stability and intracellular accumulation of quercetin by protection of the chemically or metabolically susceptible hydroxyl groups with a pivaloxymethyl (POM) promoiety J. Med. Chem. 53 2010 8597 8607
14. Lee J.S., Paul K., Alvarez M., Hose C., Monks A., Grever M., Fojo A.T., Bates S.E. Rhodamine efflux patterns predict P-glycoprotein substrates in the National Cancer Institute drug screen Mol. Pharmacol. 46 1994 627 638
15. Mi Q., Cui B., Lantvit D., Reyes-Lim E., Chai H., Pezzuto J.M., Kinghorn A.D., Swanson S.M. Pervilleine F, a new tropane alkaloid aromatic ester that reverses multidrug resistance Anticancer Res. 23 2003 3607 3615
16. Mukai R., Shirai Y., Saito N., Yoshida K.-I., Ashida H. Subcellular localization of flavonol aglycone in hepatocytes visualized by confocal laser scanning fluorescence microscope Cytotechnology 59 2009 177 182
17. Nifli A.-P., Theodoropoulos P.A., Munier S., Castagnino C., Roussakis E., Katerinopoulos H.E., Vercauteren J., Castanas E. Quercetin exhibits a specific fluorescence in cellular milieu: a valuable tool for the study of its intracellular distribution J. Agric. Food Chem. 55 2007 2873 2878
18. Ohnishi E., Bannai H. Quercetin potentiates TNF-induced antiviral activity Antiviral Res. 22 1993 327 331
19. O'Leary K.A., Day A.J., Needs P.W., Mellon F.A., O'Brien N.M., Williamson G. Metabolism of quercetin-7- and quercetin-3-glucuronides by an in vitro hepatic model: the role of human β-glucuronidase, sulfotransferase, catechol-O-methyltransferase and multi-resistant protein 2 (MRP2) in flavonoid metabolism Biochem. Pharmacol. 65 2003 479 491
20. Pearce H.L., Safa A.R., Bach N.J., Winter M.A., Cirtain M.C., Beck W.T. Essential features of the P-glycoprotein pharmacophore as defined by a series of reserpine analogs that modulate multidrug resistance Proc. Natl. Acad. Sci. U.S.A 86 1989 5128 5132
21. Scambia G., Ranelletti F.O., Benedetti Panici P., De Vincenzo R., Bonanno G., Ferrandina G., Piantelli M., Bussa S., Rumi C., Cianfriglia M., Mancuso S. Quercetin potentiates the effect of adriamycin in a multidrug-resistant MCF-7 human breast-cancer cell line: P-glycoprotein as a possible target Cancer Chemother. Pharmacol. 34 1994 459 464
22. Shepard R.L., Winter M.A., Hsaio S.C., Pearce H.L., Beck W.T., Dantzig A.H. Effect of modulators on the ATPase activity and vanadate nucleotide trapping of human P-glycoprotein Biochem. Pharmacol. 56 1998 719 727
23. Spencer J.P., Kuhnle G.G., Williams R.J., Rice-Evans C. Intracellular metabolism and bioactivity of quercetin and its in vivo metabolites Biochem. J. 372 2003 173 181
24. Tsuruo T., Iida H., Tsukagoshi S., Sakurai Y. Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil Cancer Res. 41 1981 1967 1972
25. Van der Woude H, Gliszczyńska-͆wigło A., Struijs K., Smeets A., Alink G.M., Rietjens I.M.C.M. Biphasic modulation of cell proliferation by quercetin at concentrations physiologically relevant in humans Cancer Lett. 200 2003 41 47
26. Wang E.J., Casciano C.N., Clement R.P., Johnson W.W. In vitro flow cytometry method to quantitatively assess inhibitors of P-glycoprotein Drug Metab. Dispos. 28 2000 522 528
27. Wang E.J., Casciano C.N., Clement R.P., Johnson W.W. Active transport of fluorescent P-glycoprotein substrates: evaluation as markers and interaction with inhibitors Biochem. Biophys. Res. Commun. 289 2001 580 585
28. Wesolowska O., Paprocka M., Kozlak J., Motohashi N., Dus D., Michalak K. Human sarcoma cell lines MES-SA and MES-SA/Dx5 as a model for multidrug resistance modulators screening Anticancer Res. 25 2005 383 390
29. Zídek Z., Kmoníčková E., Holý A. Cytotoxicity of pivoxil esters of antiviral acyclic nucleoside phosphonates: adefovir dipivoxil versus adefovir Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech. Repub. 149 2005 315 319